NVNO enVVeno Medical Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NVNO

Price (delayed)

$5.06

Market cap

$67.38M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.91

Enterprise value

$65.17M

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product ...

Highlights
NVNO's quick ratio has soared by 168% QoQ and by 33% YoY
The equity has surged by 85% since the previous quarter and by 19% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.hancockjaffe.com
Peers: OMER OMGA

Key stats

What are the main financial stats of NVNO
Market
Shares outstanding
13.32M
Market cap
$67.38M
Enterprise value
$65.17M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$23.52M
EBITDA
-$22.97M
Free cash flow
-$18.89M
Per share
EPS
-$1.91
Free cash flow per share
-$1.54
Book value per share
$3.47
Revenue per share
$0
TBVPS
$3.95
Balance sheet
Total assets
$48.64M
Total liabilities
$2.44M
Debt
$1.4M
Equity
$46.2M
Working capital
$45.55M
Liquidity
Debt to equity
0.03
Current ratio
34.23
Quick ratio
33.85
Net debt/EBITDA
0.1
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-64.7%
Return on equity
-70.2%
Return on invested capital
-72.7%
Return on capital employed
-49.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVNO stock price

How has the enVVeno Medical stock price performed over time
Intraday
-1.36%
1 week
-3.25%
1 month
-0.98%
1 year
26.82%
YTD
-1.56%
QTD
-7.66%

Financial performance

How have enVVeno Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.24M
Net income
-$23.52M
Gross margin
N/A
Net margin
N/A
enVVeno Medical's net income has increased by 4.7% YoY and by 2.2% from the previous quarter

Growth

What is enVVeno Medical's growth rate over time

Valuation

What is enVVeno Medical stock price valuation
P/E
N/A
P/B
1.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 13% year-on-year and by 11% since the previous quarter
The equity has surged by 85% since the previous quarter and by 19% year-on-year
The price to book (P/B) is 59% lower than the 5-year quarterly average of 3.6 and 2.7% lower than the last 4 quarters average of 1.5

Efficiency

How efficient is enVVeno Medical business performance
NVNO's ROE is down by 28% year-on-year but it is up by 8% since the previous quarter
The company's return on assets fell by 25% YoY but it rose by 7% QoQ
The ROIC has grown by 8% from the previous quarter and by 8% YoY

Dividends

What is NVNO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVNO.

Financial health

How did enVVeno Medical financials performed over time
NVNO's quick ratio has soared by 168% QoQ and by 33% YoY
enVVeno Medical's current ratio has soared by 165% from the previous quarter and by 33% YoY
NVNO's debt is 97% less than its equity
The equity has surged by 85% since the previous quarter and by 19% year-on-year
The company's debt to equity has shrunk by 50% QoQ and by 25% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.